Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bruce Light

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Journal of Physiology. Heart and Circulatory Physiology|February 12, 2008
Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparationSteven N Mink, Krika Kasian, Luis E Santos Martinez, et al.
Journal of Molecular and Cellular Cardiology|August 10, 2005
Lysozyme binding to endocardial endothelium mediates myocardial depression by the nitric oxide guanosine 3',5' monophosphate pathway in sepsisSteven N Mink, Ratna Bose, Diane E Roberts, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|January 16, 2009
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adultsColeman Rotstein, Gerald Evans, Abraham Born, et al.
Medical Mycology|July 25, 2008
Seasonal variations in the clinical presentation of pulmonary and extrapulmonary blastomycosisR Bruce Light, Doug Kralt, John M Embil, et al.
Intensive Care Medicine|December 18, 2004
Characterization of membrane N-glycan binding sites of lysozyme for cardiac depression in sepsisHans Jacobs, Steven N Mink, Krika Duke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2002
Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitalsTracy L Crampton, R Bruce Light, Greg M Berg, et al.
Chest|February 23, 2013
Mycobacterium tuberculosis septic shockShravan Kethireddy, R Bruce Light, Yazdan Mirzanejad, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 4, 2007
Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signalingSteven N Mink, Zhao-Qin Cheng, Ratna Bose, et al.
Critical Care Medicine|January 3, 2018
Culture-Negative Septic Shock Compared With Culture-Positive Septic Shock: A Retrospective Cohort StudyShravan Kethireddy, Beliz Bilgili, Amanda Sees, et al.
Critical Care Medicine|September 23, 2003
The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and resultsJean-François Dhainaut, Pierre-François Laterre, Steven P LaRosa, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Physiology. Heart and Circulatory Physiology|February 12, 2008
Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparationSteven N Mink, Krika Kasian, Luis E Santos Martinez, et al.
Journal of Molecular and Cellular Cardiology|August 10, 2005
Lysozyme binding to endocardial endothelium mediates myocardial depression by the nitric oxide guanosine 3',5' monophosphate pathway in sepsisSteven N Mink, Ratna Bose, Diane E Roberts, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|January 16, 2009
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adultsColeman Rotstein, Gerald Evans, Abraham Born, et al.
Medical Mycology|July 25, 2008
Seasonal variations in the clinical presentation of pulmonary and extrapulmonary blastomycosisR Bruce Light, Doug Kralt, John M Embil, et al.
Intensive Care Medicine|December 18, 2004
Characterization of membrane N-glycan binding sites of lysozyme for cardiac depression in sepsisHans Jacobs, Steven N Mink, Krika Duke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2002
Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitalsTracy L Crampton, R Bruce Light, Greg M Berg, et al.
Chest|February 23, 2013
Mycobacterium tuberculosis septic shockShravan Kethireddy, R Bruce Light, Yazdan Mirzanejad, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 4, 2007
Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signalingSteven N Mink, Zhao-Qin Cheng, Ratna Bose, et al.
Critical Care Medicine|January 3, 2018
Culture-Negative Septic Shock Compared With Culture-Positive Septic Shock: A Retrospective Cohort StudyShravan Kethireddy, Beliz Bilgili, Amanda Sees, et al.
Critical Care Medicine|September 23, 2003
The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and resultsJean-François Dhainaut, Pierre-François Laterre, Steven P LaRosa, et al.
Pageof 2